首頁 > 市場調查報告書 > 製藥

以基因為基之藥物開發

多體學市場規模、佔有率和成長分析（按產品/服務、類型、平台、應用、最終用戶和地區分類）—2025-2032年產業預測

市場調查報告書

商品編碼

1877997

多體學市場規模、佔有率和成長分析（按產品/服務、類型、平台、應用、最終用戶和地區分類）—2025-2032年產業預測

Multiomics Market Size, Share, and Growth Analysis, By Products and Services (Products, Services), By Type (Single-cell Multiomics, Bulk Multiomics), By Platform, By Application, By End User, By Region - Industry Forecast 2025-2032

出版日期: 2025年11月17日 | 出版商:

SkyQuest | 英文 176 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球多體學市場規模預計在 2024 年達到 31 億美元，從 2025 年的 36.1 億美元成長到 2033 年的 121.6 億美元，在預測期（2026-2033 年）內複合年成長率為 16.4%。

全球多體學市場的發展主要得益於對個人化醫療的日益重視以及基因組學和蛋白質組學研究領域的大量投資。多組體學在藥物研發和臨床診斷的應用不斷擴展，加上定序技術和數據分析的進步，正在改變製藥業和研究領域的醫療保健格局。推動多組體學需求的關鍵因素包括精準醫療的發展趨勢以及基因組學研發投入的不斷增加，而這一切都發生在慢性病盛行率不斷上升的背景下。製藥公司正在利用多組體學技術來簡化藥物研發流程、發現抗藥性並識別新的治療標靶。然而，高昂的研發成本、熟練專家的短缺、數據整合問題以及標準化程度有限等挑戰可能會阻礙市場成長。

全球體學市場促進因素

全球多體學市場的主要促進因素之一是對個人化醫療日益成長的需求。個人化醫療整合了包括基因組學、蛋白質組學和代謝體學在內的體學數據，旨在為每位患者量身定做治療方案。隨著醫療保健朝著更具針對性的治療方法和預防性方法發展，分析全面的生物學數據有助於識別疾病路徑和患者特異性的治療反應。此外，定序和數據整合技術的進步以及相關成本的下降，使得多組體學應用在臨床環境中更具可行性，從而推動了市場成長和創新。

全球多組體學市場限制因素

全球多組體學市場的主要限制因素之一是多體學技術的複雜性和高成本。整合來自基因組學、蛋白質組學和代謝體學等不同體學的數據需要先進的分析技能、尖端技術和大量資金。這種複雜性可能阻礙小規模研究機構和實驗室採用這些技術，從而限制整體市場成長。此外，監管方面的挑戰以及對跨多體學平台標準化通訊協定的需求進一步加劇了這一困境，限制了多體學在臨床實踐和研究中的廣泛應用，並阻礙了市場擴張。

全球體學市場趨勢

全球多組體學市場正經歷向臨床應用，特別是精準醫療領域，的重大轉變。多體學領域的企業正積極尋求將診斷技術應用於包括腫瘤學、心血管疾病和神經病學在內的各個領域。這種對臨床應用的關注將有助於疾病的早期發現，改善個人化治療，並最終提升患者的治療效果。隨著基於多組體學的診斷工具日益普及，預計將為市場參與企業創造大量機遇，增強其競爭優勢，並促進推動醫療創新邊界的合作。這一趨勢凸顯了醫療解決方案向數據驅動型解決方案的重大轉變。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Thermo Fisher Scientific Inc.（United States）
Illumina, Inc.（United States）
Danaher Corporation（United States）
QIAGEN NV（Germany）
Agilent Technologies, Inc.（United States）
PerkinElmer, Inc.（United States）
Bruker Corporation（United States）
Becton, Dickinson and Company（BD）（United States）
F. Hoffmann-La Roche Ltd.（Switzerland）
10x Genomics, Inc.（United States）
Shimadzu Corporation（Japan）
BGI Genomics（China）
Bio-Rad Laboratories, Inc.（United States）
Mission Bio, Inc.（United States）
Standard BioTools（United States）
NanoString Technologies（United States）
CYTENA GmbH（Germany）
Tempus Labs, Inc.（United States）
DNAnexus, Inc.（United States）
Eurofins Scientific SE（Luxembourg）

結論與建議

簡介目錄

Product Code: SQMIG35G2367

Global Multiomics Market size was valued at USD 3.1 billion in 2024 and is poised to grow from USD 3.61 billion in 2025 to USD 12.16 billion by 2033, growing at a CAGR of 16.4% during the forecast period (2026-2033).

The global multiomics market is driven by a heightened emphasis on personalized medicine, along with significant investments in genomics and proteomics research. The increasing application of multiomics in drug discovery and clinical diagnostics, coupled with advances in sequencing and data analysis, is reshaping the healthcare landscape across pharmaceutical and research sectors. A pivotal aspect fueling demand for multiomics is the trend towards precision medicine, alongside growing investment in genomic R&D amidst rising chronic disease prevalence. Pharmaceutical companies are harnessing multiomics technologies to enhance drug discovery, elucidate drug resistance, and pinpoint new therapeutic targets. However, challenges such as high research costs, a shortage of skilled professionals, data integration issues, and limited standardization may hinder market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Multiomics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Multiomics Market Segments Analysis

Global Multiomics Market is segmented by Products and Services, Type, Platform, Application, End User and region. Based on Products and Services, the market is segmented into Products and Services. Based on Type, the market is segmented into Single-cell Multiomics and Bulk Multiomics. Based on Platform, the market is segmented into Genomics, Transcriptomics, Proteomics, Metabolomics and Integrated Omics Platforms. Based on Application, the market is segmented into Diagnostics, Drug Discovery and Development, Personalized Medicine, AgriGenomics and Others. Based on End User, the market is segmented into Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Clinical Research Organizations (CROs) and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Multiomics Market

One key market driver for the global multiomics market is the increasing demand for personalized medicine, which leverages the integration of genomics, proteomics, metabolomics, and other omics data to tailor treatments to individual patients. As healthcare shifts towards more targeted therapies and preventive approaches, the ability to analyze comprehensive biological data helps identify disease pathways and patient-specific responses to treatments. Furthermore, advancements in technology and decreasing costs associated with sequencing and data integration are enhancing the feasibility of multiomics applications in clinical settings, thus driving growth and innovation within the market.

Restraints in the Global Multiomics Market

One significant market restraint for the global multiomics market is the high complexity and cost associated with multiomics technologies. The integration of various omics data, such as genomics, proteomics, and metabolomics, requires advanced analytical skills, sophisticated technologies, and substantial financial resources. This complexity can deter smaller research institutions and laboratories from adopting these technologies, limiting overall market growth. Additionally, regulatory challenges and the need for standardized protocols across multiomics platforms further complicate the landscape, restricting the widespread application of multiomics in clinical practice and research, thereby hindering market expansion.

Market Trends of the Global Multiomics Market

The Global Multiomics market is experiencing a significant shift towards clinical applications, particularly in precision medicine. Companies within the multiomics sector are strategically innovating to leverage their technologies for diagnostics across various domains, including oncology, cardiovascular health, and neurology. This focus on clinical translation is enhancing early disease detection and improving treatment personalization, ultimately driving better patient outcomes. As multiomics-based diagnostic tools gain traction, they are expected to create substantial opportunities for market participants, solidifying their competitive edge and fostering collaborations that push the boundaries of healthcare innovation. The trend underscores a pivotal move towards data-driven healthcare solutions.

Introduction

Objectives of the Study
Market Definition & Scope

Research Methodology

Research Process
Secondary & Primary Data Methods
Market Size Estimation Methods

Executive Summary

Global Market Outlook
Key Market Highlights
Segmental Overview
Competition Overview

Market Dynamics & Outlook

Macro-Economic Indicators
Drivers & Opportunities
Restraints & Challenges
Supply Side Trends
Demand Side Trends
Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors
Market Impacting Factors
Top Investment Pockets
Ecosystem Mapping
Market Attractiveness Index, 2025
PESTEL Analysis
Value Chain Analysis
Pricing Analysis
Case Studies
Regulatory Landscape
Technology Assessment

Global Multiomics Market Size by Products and Services & CAGR (2026-2033)

Market Overview
Products
- Instruments
- Consumables
- Software
Services

Global Multiomics Market Size by Type & CAGR (2026-2033)

Market Overview
Single-cell Multiomics
Bulk Multiomics

Global Multiomics Market Size by Platform & CAGR (2026-2033)

Market Overview
Genomics
Transcriptomics
Proteomics
Metabolomics
Integrated Omics Platforms

Global Multiomics Market Size by Application & CAGR (2026-2033)

Market Overview
Diagnostics
Drug Discovery and Development
Personalized Medicine
AgriGenomics
Others

Global Multiomics Market Size by End User & CAGR (2026-2033)

Market Overview
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Clinical Research Organizations (CROs)
Others

Global Multiomics Market Size & CAGR (2026-2033)

North America (Products and Services, Type, Platform, Application, End User)
- US
- Canada
Europe (Products and Services, Type, Platform, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Products and Services, Type, Platform, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Products and Services, Type, Platform, Application, End User)
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa (Products and Services, Type, Platform, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Thermo Fisher Scientific Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN N.V. (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bruker Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (BD) (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
10x Genomics, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shimadzu Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BGI Genomics (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mission Bio, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Standard BioTools (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NanoString Technologies (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CYTENA GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tempus Labs, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DNAnexus, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific S.E. (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments